Insilico Medicine Publishes Phase IIa Results in Nature Medicine on Rentosertib, Novel AI-Designed TNIK Inhibitor for Idiopathic Pulmonary Fibrosis
In a groundbreaking advancement in pharmaceutical science, Insilico Medicine has unveiled the first proof-of-concept clinical validation of a drug discovered ...
